GPT and metabolic dysfunction-associated steatohepatitis: However, mice treated with UP601 showed significantly improved NASH scores in lobular inflammation and hepatocellular ballooning without affecting the liver enzymes (AST and ALT) suggesting the composition may have an indication in fatty liver disease without associated adverse effects.